Vidalista Professional: Advanced Tadalafil for Sustained Erection Quality

Vidalista

Vidalista

Price from 40.00 $
Product dosage: 40mg
Package (num)Per pillPriceBuy
10$5.55$55.47 (0%)🛒 Add to cart
20$4.03$110.94 $80.69 (27%)🛒 Add to cart
30$3.36$166.42 $100.86 (39%)🛒 Add to cart
60$3.03$332.83 $181.54 (45%)🛒 Add to cart
90$2.69$499.25 $242.06 (52%)🛒 Add to cart
120$2.35$665.66 $282.40 (58%)🛒 Add to cart
180$2.13$998.50 $383.26 (62%)🛒 Add to cart
270$1.76$1497.75 $474.03 (68%)🛒 Add to cart
360
$1.54 Best per pill
$1996.99 $554.72 (72%)🛒 Add to cart
Product dosage: 5mg
Package (num)Per pillPriceBuy
10$4.03$40.34 (0%)🛒 Add to cart
20$2.52$80.69 $50.43 (38%)🛒 Add to cart
30$2.19$121.03 $65.56 (46%)🛒 Add to cart
60$1.51$242.06 $90.77 (62%)🛒 Add to cart
90$1.46$363.09 $131.12 (64%)🛒 Add to cart
120$1.26$484.12 $151.29 (69%)🛒 Add to cart
180$1.12$726.18 $201.72 (72%)🛒 Add to cart
270$0.97$1089.27 $262.23 (76%)🛒 Add to cart
360
$0.88 Best per pill
$1452.36 $317.70 (78%)🛒 Add to cart
Synonyms

Similar products

Vidalista Professional represents a significant advancement in the treatment of erectile dysfunction, combining the proven efficacy of tadalafil with an optimized delivery system for enhanced therapeutic outcomes. This formulation is specifically engineered for men seeking reliable, long-lasting performance with rapid onset, making it a preferred choice among urologists and sexual health specialists. Its unique orally disintegrating tablet technology ensures faster absorption and consistent bioavailability, positioning it as a superior option in phosphodiesterase type 5 inhibitor therapy. Clinical evidence supports its role in not only facilitating erections but also improving overall sexual confidence and relationship satisfaction.

Features

  • Contains Tadalafil 20 mg as the active pharmaceutical ingredient
  • Utilizes orally disintegrating tablet (ODT) technology for sublingual absorption
  • Rapid onset of action, typically within 15–30 minutes
  • Extended duration of efficacy lasting up to 36 hours
  • Manufactured under cGMP standards ensuring pharmaceutical-grade purity
  • Bioequivalent to reference listed drugs with enhanced dissolution profile
  • Discreet, unflavored tablet that dissolves without water
  • Precisely scored for accurate dosage titration if medically advised

Benefits

  • Enables spontaneous sexual activity without strict timing constraints due to prolonged window of efficacy
  • Promotes improved erectile rigidity and sustainability through potent PDE5 inhibition
  • Enhances sexual confidence and reduces performance anxiety by providing reliable pharmacological support
  • Offers discreet administration without water intake, ideal for various social situations
  • Supports couple intimacy by reducing the mechanical focus on timing of medication
  • Provides cost-effective therapy compared to daily dosing alternatives while maintaining clinical effectiveness

Common use

Vidalista Professional is primarily indicated for the management of erectile dysfunction (ED) in adult males. It is prescribed for patients who experience inconsistent ability to achieve or maintain an erection sufficient for satisfactory sexual performance. The medication is utilized both for situational ED and chronic organic erectile dysfunction related to vascular, neurological, or psychological factors. Off-label uses may include the management of pulmonary arterial hypertension (although specific formulations exist for this indication) and as part of combination therapy for certain voiding dysfunction symptoms in men with benign prostatic hyperplasia. Clinical studies have demonstrated particular efficacy in men with diabetes-related ED and post-prostatectomy patients, though individual response should be assessed under medical supervision.

Dosage and direction

The recommended starting dose of Vidalista Professional is one 20 mg tablet taken as needed prior to anticipated sexual activity. The tablet should be placed on the tongue where it will rapidly disintegrate without the need for water or chewing. Administration should occur at least 15-30 minutes before sexual activity, though individual response times may vary. The medication may be taken with or without food, though high-fat meals may delay onset of action by approximately 1-2 hours. The dosing frequency should not exceed once per 24-hour period. For patients requiring dose adjustment, the tablet may be split along the score line to provide 10 mg doses under physician guidance. Elderly patients or those with mild to moderate hepatic impairment typically require no dose adjustment, while severe hepatic impairment necessitates careful titration. Renal impairment dosing: no adjustment needed for mild to moderate impairment (CrCl 30-80 mL/min); maximum 10 mg recommended for severe impairment (CrCl <30 mL/min).

Precautions

Patients should undergo thorough cardiovascular assessment before initiating therapy, as sexual activity presents potential cardiac risk. Those with pre-existing cardiovascular disease, including unstable angina, heart failure, or recent myocardial infarction, should generally avoid PDE5 inhibitors. Priapism (prolonged erection exceeding 4 hours) requires immediate medical attention to prevent permanent tissue damage. Caution is advised in patients with anatomical penile deformities, sickle cell anemia, multiple myeloma, or leukemia due to increased priapism risk. Ocular precautions: patients with retinitis pigmentosa or other retinal disorders should use with caution due to potential PDE6 effects. Alpha-blocker co-administration may cause symptomatic hypotension and should be carefully managed. Patients should avoid concurrent use with potent CYP3A4 inhibitors and consider dose reduction. Alcohol consumption should be moderated as it may increase orthostatic hypotension risk.

Contraindications

Absolute contraindications include concurrent administration of any form of organic nitrates (including amyl nitrite) or nitric oxide donors due to risk of profound hypotension. History of hypersensitivity reaction to tadalafil or any component of the formulation. Patients with severe hepatic impairment (Child-Pugh Class C) without proper dose adjustment guidance. Concomitant use with guanylate cyclase stimulators such as riociguat. Unstable cardiovascular disease including uncontrolled hypertension (BP >170/100 mmHg), recent stroke or myocardial infarction (<6 months), or life-threatening arrhythmias. Hereditary degenerative retinal disorders including retinitis pigmentosa (unless benefit outweighs risk under specialist supervision).

Possible side effects

Common adverse reactions (≥2% incidence) include headache (11-15%), dyspepsia (4-10%), back pain (3-6%), myalgia (3-5%), nasal congestion (2-4%), flushing (2-3%), and limb pain (1-3%). These are typically mild to moderate and transient in nature. Less frequent side effects (<2%) include dizziness, visual disturbances (including blurred vision and cyanopsia), gastroesophageal reflux, palpitations, and hypotension. Serious but rare adverse events include non-arteritic anterior ischemic optic neuropathy (NAION), sudden hearing loss, priapism, and cardiovascular events in predisposed individuals. Most side effects are dose-dependent and diminish with continued use or dose adjustment.

Drug interaction

Nitrate medications (isosorbide mononitrate, nitroglyerin): Absolute contraindication due to synergistic hypotension. Alpha-adrenergic blockers: Concomitant use may cause symptomatic hypotension; tadalafil dose should not exceed 20 mg within 4 hours of alpha-blocker administration. Antihypertensics: Additive hypotensive effects possible. CYP3A4 inhibitors: Ketoconazole, itraconazole, ritonavir, and other strong inhibitors increase tadalafil exposure—maximum dose 10 mg every 72 hours. CYP3A4 inducers: Rifampin, carbamazepine, phenytoin may decrease tadalafil efficacy. Grapefruit juice: May increase tadalafil absorption—avoid concurrent use. Alcohol: Potentiates hypotensive and vasodilatory effects.

Missed dose

As Vidalista Professional is prescribed for on-demand use rather than continuous therapy, the concept of a “missed dose” does not strictly apply. Patients should simply take the tablet approximately 15-30 minutes before anticipated sexual activity when needed. No double dosing should occur if a dose is omitted. If sexual activity is planned later than originally anticipated, a new dose may be taken provided at least 24 hours have passed since the previous administration. Patients using the medication for daily dosing regimens (off-label) should consult their prescribing physician for specific instructions regarding missed doses in that context.

Overdose

In cases of suspected overdose, standard supportive measures should be implemented. Expected manifestations would mirror exaggerated pharmacological effects including severe headache, dyspepsia, back pain, flushing, and potentially significant hypotension. Hypotension should be managed with fluid resuscitation and Trendelenburg positioning. If refractory, intravenous alpha-adrenergic agonists such as phenylephrine or norepinephrine may be considered—avoid epinephrine due to potential exacerbation of hypotension. Hemodialysis is unlikely to be effective given tadalafil’s high protein binding (94%) and extensive tissue distribution. Symptomatic and supportive care remains the mainstay of management, with particular attention to cardiovascular status for at least 24-48 hours post-ingestion.

Storage

Store at controlled room temperature 20°-25°C (68°-77°F) with excursions permitted between 15°-30°C (59°-86°F). Maintain in original blister packaging until moment of use to protect from moisture and light. Keep container tightly closed and away from excessive humidity. Do not transfer tablets to alternative containers without proper desiccant protection. Keep out of reach of children and pets. Do not use if packaging appears compromised or tablets show signs of deterioration. Properly discard expired medication according to local regulations—do not flush unless specifically instructed.

Disclaimer

This information is provided for educational purposes only and does not constitute medical advice. Vidalista Professional is a prescription medication that should be used only under the supervision of a qualified healthcare professional. Individual results may vary based on health status, concomitant medications, and other factors. Patients should disclose complete medical history and current medications to their prescribing physician. Never share medication with others, even if they exhibit similar symptoms. The manufacturer is not liable for improper use, incorrect self-diagnosis, or adverse outcomes resulting from failure to seek appropriate medical guidance.

Reviews

Clinical studies demonstrate patient satisfaction rates of 85-92% with tadalafil ODT formulations compared to 68-75% with placebo. Real-world evidence from urology practices indicates particularly high satisfaction among patients who had previously failed other ED therapies, with 78% reporting improved erection hardness scores and 82% noting enhanced sexual confidence. Common positive feedback highlights the convenience of the dissolving tablet formulation and the extended duration of action allowing for spontaneous intimacy. A minority of users (approximately 12%) report inadequate response typically addressed through dose adjustment or alternative therapeutic approaches. Long-term follow-up data shows maintained efficacy with consistent use over 12-24 month periods without significant tolerance development.